In this episode, Brent Buchanan and Alex Tarascio break down Cygnal's latest national voter poll, which reveals that GLP-1 medications have become a mainstream part of the healthcare conversation. The data shows that more than one-third of likely voters are currently using, have used, or are considering GLP-1s, challenging the perception that these medications are only for affluent consumers or cosmetic weight loss. The discussion explores who is using GLP-1s, why they're using them, and what voters think about safety, Medicare coverage, and the future of access to these treatments.
For more information and the full deck, reach out to our experts here!